Technology-enabled Approval Acceleration: Spotlighting the ICH S1B Weight of Evidence

The ICH S1B WoE directive is a real game-changer for the pharma industry In this White Paper you will learn the importance and significance of the recent ICH S1B Guideline, and how technology-enabled approaches, such as Artificial Intelligence (AI) and Machine Learning (ML), can enhance the production of a WoE.

The ICH S1B WoE directive is a real game-changer for the pharma industry

In this White Paper you will learn the importance and significance of the recent ICH S1B Guideline, and how technology-enabled approaches, such as Artificial Intelligence (AI) and Machine Learning (ML), can enhance the production of a WoE.

Get This Resource

First Name(Required)

Last Name(Required)

Company Name(Required)

Job Title(Required)

Email(Required)

Country(Required)

U.S State(Required)

Canadian Province(Required)

Newsletter Optin

I want to receive periodic industry insights, event invitations, product updates, and other information from Instem.

Privacy Optin(Required)

I agree to the Instem Privacy Policy

This field is for validation purposes and should be left unchanged.

Share This Resource

Technology-enabled Approval Acceleration: Spotlighting the ICH S1B Weight of Evidence

Request a Demo Today